164 related articles for article (PubMed ID: 1497689)
21. An open, long-term, multi-centre study of the anti-anginal efficacy and safety of isosorbide 5-mononitrate at low doses in patients with coronary heart disease.
Uberbacher HJ; Steinorth G; Glocke M; Abshagen U
Pharmatherapeutica; 1983; 3(5):331-41. PubMed ID: 6342004
[TBL] [Abstract][Full Text] [Related]
22. Effect of extended-release isosorbide mononitrate one hour after dosing in patients with stable angina pectoris. IMDUR Study Group.
Glasser SP
Am J Cardiol; 1997 Dec; 80(12):1546-50. PubMed ID: 9416933
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of isosorbide-5-mononitrate on effort-induced electrocardiographic ischemic changes in patients with angina pectoris.
Brunner D; Meshulam N; Weisbort J
Int J Cardiol; 1987 Sep; 16(3):303-7. PubMed ID: 3654028
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of controlled-release isosorbide-5-mononitrate in Japanese patients with stable effort angina pectoris.
Shimada K; Sunayama S; Nakazato K; Satoh H; Kusama Y; Kawakubo K; Daida H
Int Heart J; 2006 Sep; 47(5):695-705. PubMed ID: 17106140
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
Reifart N; Reifart F; Kaltenbach M; Bussmann WD
Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
[No Abstract] [Full Text] [Related]
26. Effects of isosorbide-5-mononitrate on exercise-induced hemodynamic changes in angina pectoris.
Yokota M; Tsunekawa A; Miyahara T; Kamihara S; Kitamura J; Noda S; Koide M; Tsuzuki M; Sotobata I
Am J Cardiol; 1986 Jul; 58(1):53-8. PubMed ID: 3728331
[TBL] [Abstract][Full Text] [Related]
27. Isosorbide-5-mononitrate and isosorbide dinitrate retard in the treatment of coronary heart disease: a multi-centre study.
Bidoggia H
Curr Med Res Opin; 1987; 10(9):601-11. PubMed ID: 3325229
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy of isosorbide-5-mononitrate retard in patients with stable exertional angina].
Demin AA; Aksenova EA
Klin Med (Mosk); 2005; 83(9):53-6. PubMed ID: 16279042
[TBL] [Abstract][Full Text] [Related]
29. [Isosorbide-5-mononitrate in angina pectoris: its efficacy and absence of tolerance and rebound with an eccentric type of administration].
Schneeweiss A; Reisin L; Marmor A; Caspi A
Cardiology; 1994; 84 Suppl 1():4-12. PubMed ID: 8087823
[TBL] [Abstract][Full Text] [Related]
30. Abrupt withdrawal of isosorbide 5-mononitrate (Imdur) after long term treatment in stable angina pectoris. A preliminary report.
Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Härkönen R
Drugs; 1987; 33 Suppl 4():118-21. PubMed ID: 2887419
[TBL] [Abstract][Full Text] [Related]
31. Comparison between felodipine and isosorbide mononitrate as adjunct to beta blockade in patients > 65 years of age with angina pectoris.
de Vries RJ; Dunselman PH; van Veldhuisen DJ; van den Heuvel AF; Wielenga RP; Lie KI
Am J Cardiol; 1994 Dec; 74(12):1201-6. PubMed ID: 7977090
[TBL] [Abstract][Full Text] [Related]
32. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
Ciopor M; Fischer A; Turina J; Hess OM
Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
[TBL] [Abstract][Full Text] [Related]
33. The therapeutic role of isosorbide-5-mononitrate+ in stable and unstable angina pectoris.
Distante A; Lombardi M; Moscarelli E; Morales MA; L'Abbate A
Z Kardiol; 1986; 75 Suppl 3():38-41. PubMed ID: 3541417
[TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of Hartone in stable angina pectoris--an open comparative trial.
Kumar PU; Adhikari P; Pereira P; Bhat P
J Assoc Physicians India; 1999 Jul; 47(7):685-9. PubMed ID: 10778587
[TBL] [Abstract][Full Text] [Related]
35. [Delayed-action isosorbide-5-mononitrate preparations--are there differences in the acute effect?].
Jansen W; Geppert R; Weidmann B; Tauchert M
Med Klin (Munich); 1987 Nov; 82(24):854-9. PubMed ID: 3431518
[No Abstract] [Full Text] [Related]
36. [Influence of isosorbide-5-mononitrate on the tolerance test to exertion in angina pectoris].
Cherchi A; Lai C; Onnis E; Cherchi A; Meloni L; Pirisi R
Cardiologia; 1985 Jun; 30(6):439-48. PubMed ID: 3833355
[No Abstract] [Full Text] [Related]
37. Treatment of angina pectoris with isosorbide-5-mononitrate. A multicenter study in general practice.
Beck EJ; Koch JE
Cardiology; 1991; 79 Suppl 2():41-5. PubMed ID: 1760828
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of isosorbide-5-mononitrate on painful and silent myocardial ischemia after myocardial infarction.
Feng JZ; Feng XH; Schneeweiss A
Am J Cardiol; 1990 Jun; 65(21):32J-35J. PubMed ID: 2190460
[TBL] [Abstract][Full Text] [Related]
39. [High-dose single administration of isosorbide dinitrate: effect on diurnal distribution of transitory myocardial ischemia in patients with stable angina pectoris].
Hausmann D; Nikutta P; Daniel WG; Hartwig CA; Wenzlaff P; Lichtlen PR
Z Kardiol; 1989 Jul; 78(7):415-20. PubMed ID: 2672651
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis of cost-effectiveness between isosorbide-5-mononitrate and isosorbide: a retrospective real-world evaluation.
Zhang G; Liu X; Xu J; Cheng G; Xu J
J Comp Eff Res; 2020 Apr; 9(6):405-412. PubMed ID: 32301331
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
